Utilizing New Technologies to Educate & Inform Patients of New Diabetes Product Launches
CHAPEL HILL, N.C., June 13, 2014 /PRNewswire/ -- The diabetes therapeutic area continues to advance as the bio-pharma industry finds success with new treatment options. Despite the tremendous amount of opportunities that exist, organizations are also faced with lots of competition in the marketplace. Understanding how to utilize and adapt new technologies and therapeutic approaches when launching a new product can help to set organizations apart.
According to research by benchmarking firm, Best Practices, LLC, new technologies and public relations are both "leveraged", cost-efficient tools for marketplace education. The development and pre-launch cycle offer many opportunities to use new technologies, such as Social Media, Internet, and YouTube/Video communication channels, to educate physicians, patients, payers and government.
The report, "Shaping the Marketplace to Support Successful Diabetes Product Launches: Tactics for Educating KOLs, Physicians, Patients and Payers," provides leaders with benchmark metrics on the most effective physician, payer and patient education practices conducted from clinical development through launch. Executives and managers involved in market education efforts for new products can use this research to compare their market education tactics and strategies with those of leading organizations.
Key Topics of this report include:
- Identification of Key Education Tactics for Thought Leaders, Physicians, Patients, and Payers
- Identification of Key Timing for Educational Activities for KOLs, Physicians, Patients and Payers
- Assessment of Key Market Education Practices, including Thought Leader Activities, CME, Scientific Publication Strategy and Tactics, Patients and Patient Advocacy Education, Clinical Trials & Payer Education
- Description of Critical Market Education Pitfalls and Future Trends
The research- which includes Diabetes and total benchmark class segments- attracted 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies, including 13 of the Top 20 pharmaceutical companies. Additionally, the research reflects on nine deep-dive interviews with selected participants.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1294.htm.
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.